The U.S. Department of Justice dismisses a lawsuit against Fresenius Medical Care AG, which was accused of running a scheme to overcharge Medicare for kidney dialysis services.

The U.S. Department of Justice dropped a lawsuit against Fresenius Medical (NYSE:FMS), which was accused of overcharging Medicare for kidney dialysis services.
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-...
The FDA slaps its highest-risk classification on Abbott Labs' FreeStyle InsuLinx blood glucose meter...
Weight-loss devices maker GI Dynamics tells investors today that the company may seek new funding as...
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent...
Covidien restates its financial results for its fiscal 2nd quarter ahead of the spinout of its...